American Journal of Kidney Diseases
Volume 50, Issue 4 , Pages 559-565 , October 2007

Predicting Renal Replacement Therapy and Mortality in CKD

  • Eric S. Johnson, PhD

      Affiliations

    • Center for Health Research, Kaiser Permanente Northwest, Portland, OR
    • ,
  • Micah L. Thorp, DO, MPH

      Affiliations

    • Department of Nephrology, Kaiser Permanente Northwest, Portland, OR
    • ,
  • Xiuhai Yang, MS

      Affiliations

    • Center for Health Research, Kaiser Permanente Northwest, Portland, OR
    • ,
  • Olivier L. Charansonney, MD, PhD, MBA

      Affiliations

    • Sanofi-Aventis, Paris, France.
    • ,
  • David H. Smith, RPh, PhD

      Affiliations

    • Center for Health Research, Kaiser Permanente Northwest, Portland, OR
    • Corresponding Author InformationAddress correspondence to David H. Smith, RPh, PhD, Center for Health Research, Kaiser Permanente Northwest, 3800 N Interstate Ave, Portland, OR 97227.

Received 18 December 2006 ,Accepted 5 July 2007.

References 

  1. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180–188
  2. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307–1315
  3. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  4. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663
  5. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  6. Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int. 2006;70:1694–1705
  7. Guyatt GH. Determining prognosis and creating clinical decision rules. In:  Haynes RB,  Sackett DL,  Guyatt GH,  Tugwell P editor. Clinical Epidemiology. ed 3. Philadelphia, PA: Lippincott Williams & Wilkins; 2006;p. 323–355
  8. Selby JV, Smith DH, Johnson ES, Raebel MA, Friedman GD, McFarland BH. Kaiser Permanente Medical Care Program, in Pharmacoepidemiology. In: ed 4. New York, NY: Wiley; 2005;p. 241–259
  9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130:461–470
  10. Smith LR, Harrell FE, Muhlbaier LH. Problems and potentials in modeling survival. In:  Grady ML,  Schwartz HA editor. Medical Effectiveness Research Data Methods (Summary Report). Rockville, MD: US Department of Health and Human Services, Agency for Health Care Policy and Research; 1992;p. 151–159AHCPR Pub No. 92-0056
  11. Harrell FE. Cox proportional hazards regression model. In:  Harrell FE editors. Regression Modeling Strategies. New York, NY: Springer; 2001;p. 465–507
  12. Harrell FE. Missing data. In:  Harrell FE editors. Regression Modeling Strategies. New York, NY: Springer; 2001;p. 41–52
  13. Lin DY. Cox regression analysis of multivariate failure time data: The marginal approach. Stat Med. 1994;13:2233–2247
  14. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137:479–486
  15. Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int. 2006;70:1694–1705
  16. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med. 2006;355:2615–2617
  17. Nurmohamed SA, Nubé MJ. Reverse epidemiology: Paradoxical observations in haemodialysis patients. Neth J Med. 2005;63:376–381
  18. Kopple JD. The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. Am J Clin Nutr. 2005;81:1257–1266
  19. Kalantar-Zadeh K, Block G, Horwich T, et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004;43:1439–1444
  20. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, et al. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant. 2006;21:1257–1262
  21. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005;165:923–928
  22. Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int. 2006;70:1694–1705
  23. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, et al. Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int. 2006;69:560–564
  24. Feldman HI, Appel LJ, Chertow GM, et al. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and methods. J Am Soc Nephrol. 2003;14(suppl):S148–S153
  25. Rao M, Kausz AT, Mitchell D, et al. The Study of Treatment for Renal Insufficiency: Data and Evaluation (STRIDE), a national registry of chronic kidney disease. Semin Dial. 2002;15:366–369

PII: S0272-6386(07)01035-9

doi: 10.1053/j.ajkd.2007.07.006

American Journal of Kidney Diseases
Volume 50, Issue 4 , Pages 559-565 , October 2007

Article Tools